NDC 68382-075

Risedronate Sodium

Risedronate Sodium

Risedronate Sodium is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Zydus Pharmaceuticals Usa Inc.. The primary component is Risedronate Sodium Anhydrous.

Product ID68382-075_3cbf30c0-30dd-4022-88b6-86a84697379c
NDC68382-075
Product TypeHuman Prescription Drug
Proprietary NameRisedronate Sodium
Generic NameRisedronate Sodium
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2019-04-10
Marketing CategoryANDA / ANDA
Application NumberANDA203822
Labeler NameZydus Pharmaceuticals USA Inc.
Substance NameRISEDRONATE SODIUM ANHYDROUS
Active Ingredient Strength35 mg/1
Pharm ClassesBisphosphonate [EPC], Diphosphonates [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 68382-075-73

1 BLISTER PACK in 1 CARTON (68382-075-73) > 4 TABLET, DELAYED RELEASE in 1 BLISTER PACK
Marketing Start Date2019-04-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68382-075-73 [68382007573]

Risedronate Sodium TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA203822
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-10

Drug Details

Active Ingredients

IngredientStrength
RISEDRONATE SODIUM ANHYDROUS35 mg/1

OpenFDA Data

SPL SET ID:04e4baa7-62a5-45d0-8f8d-a4daea68c5aa
Manufacturer
UNII

Pharmacological Class

  • Bisphosphonate [EPC]
  • Diphosphonates [CS]

Medicade Reported Pricing

68382075910 METFORMIN HCL 850 MG TABLET

Pricing Unit: EA | Drug Type:

68382075905 METFORMIN HCL 850 MG TABLET

Pricing Unit: EA | Drug Type:

68382075901 METFORMIN HCL 850 MG TABLET

Pricing Unit: EA | Drug Type:

68382075810 METFORMIN HCL 500 MG TABLET

Pricing Unit: EA | Drug Type:

68382075805 METFORMIN HCL 500 MG TABLET

Pricing Unit: EA | Drug Type:

68382075801 METFORMIN HCL 500 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Risedronate Sodium" or generic name "Risedronate Sodium"

NDCBrand NameGeneric Name
0093-3098Risedronate SodiumRisedronate Sodium
0093-3099Risedronate SodiumRisedronate Sodium
0093-3100Risedronate SodiumRisedronate Sodium
0093-7771Risedronate SodiumRisedronate Sodium
0378-4044Risedronate Sodiumrisedronate sodium
0378-4114Risedronate Sodiumrisedronate sodium
0378-4150Risedronate Sodiumrisedronate sodium
0378-4714Risedronate Sodiumrisedronate sodium
0591-2067risedronate sodiumrisedronate sodium
0591-2109risedronate sodiumrisedronate sodium
0591-2075risedronate sodiumrisedronate sodium
0591-2044risedronate sodiumrisedronate sodium
0591-2102risedronate sodiumrisedronate sodium
0591-3876Risedronate SodiumRisedronate Sodium
33342-107Risedronate SodiumRisedronate Sodium
33342-109Risedronate SodiumRisedronate Sodium
33342-108Risedronate SodiumRisedronate Sodium
47335-666risedronate sodiumrisedronate sodium
47335-667risedronate sodiumrisedronate sodium
47335-928risedronate sodiumrisedronate sodium
47335-727risedronate sodiumrisedronate sodium
47335-668risedronate sodiumrisedronate sodium
59762-0405Risedronate SodiumRisedronate Sodium
59762-0406Risedronate SodiumRisedronate Sodium
59762-0407Risedronate SodiumRisedronate Sodium
60505-3165Risedronate SodiumRisedronate Sodium
60723-041Risedronate SodiumRisedronate Sodium
60505-3096Risedronate SodiumRisedronate Sodium
60505-3097Risedronate SodiumRisedronate Sodium
65862-517Risedronate SodiumRisedronate Sodium
65862-518Risedronate SodiumRisedronate Sodium
65862-519Risedronate SodiumRisedronate Sodium
65862-870Risedronate SodiumRisedronate Sodium
68382-075Risedronate SodiumRisedronate Sodium
70771-1436Risedronate SodiumRisedronate Sodium
63304-440RISEDRONATE SODIUMRISEDRONATE SODIUM
0149-0470ACTONELRISEDRONATE SODIUM
0149-0471ACTONELRISEDRONATE SODIUM
0149-0472ACTONELRISEDRONATE SODIUM
0149-0478ACTONELRISEDRONATE SODIUM
0430-0470ActonelRisedronate Sodium
0430-0471ActonelRisedronate Sodium
0430-0472ActonelRisedronate Sodium
0430-0478ActonelRisedronate Sodium

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.